Recludix Pharma Funding: $60M Raised, Series A (2021)

Recludix Pharma is based in San Diego, CA. It has raised $60M in total funding. Latest round: Series A.

Recludix Pharma funding overview

Recludix Pharma is based in San Diego, CA. Recludix Pharma has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2021. The round record for Recludix Pharma runs through 2021; nothing later has been disclosed. Investors on record include NEA, Westlake Village BioPartners, Access Biotechnology, Eli Lilly and Company. 4 distinct backers are named across the disclosed rounds.

Recludix Pharma at a glance

Total raised
$60M
Latest round
Series A
Latest round date
November 2021
Headquarters
San Diego, CA
Notable investors
NEA, Westlake Village BioPartners, Access Biotechnology, Eli Lilly and Company

Frequently asked about Recludix Pharma funding

How much has Recludix Pharma raised?
Recludix Pharma has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Recludix Pharma?
NEA, Westlake Village BioPartners, Access Biotechnology, Eli Lilly and Company are named among the investors backing Recludix Pharma.
What was the latest Recludix Pharma funding round?
The most recent disclosed round is a Series A, announced in November 2021.
Where is Recludix Pharma based?
Recludix Pharma is based in San Diego, CA.
When did Recludix Pharma last raise?
The last disclosed Recludix Pharma round closed in November 2021 at Series A.

Every Recludix Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.

Companies related to Recludix Pharma (36)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026